Compounds > androstane-3,17-diol
Page last updated: 2024-08-23

androstane-3,17-diol and Hyperplasia

androstane-3,17-diol has been researched along with Hyperplasia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, S; Bergerheim, U; Butler, R; Gustafsson, JÅ; Kim, HJ; Muthusamy, S; Waage, L1
Bandieramonte, G; Dati, V; Di Pietro, S; Fariselli, G; Recchione, C; Secreto, G1
Dube, JY; Frenette, G; Tremblay, RR1
Cavazos, LF; Charles, JF; Floch, HH; Leav, I; Morfin, RF; Ofner, P1
Barbolt, TA; Dube, JY; Egy, MA; Frenette, G; Juniewicz, PE; Tremblay, RR1
Fava-De-Moraes, F; Minetti, CA; Oliveira-Filho, RM; Valle, LB1

Other Studies

6 other study(ies) available for androstane-3,17-diol and Hyperplasia

ArticleYear
Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Dec-13, Volume: 108, Issue:50

    Topics: Androstane-3,17-diol; Cell Proliferation; Dihydrotestosterone; Epithelium; Estrogen Receptor beta; HEK293 Cells; Humans; Hyperplasia; Immunohistochemistry; Male; Models, Biological; Prostate; Prostatic Neoplasms; Racemases and Epimerases; Signal Transduction; Transcriptional Activation

2011
Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:1

    Topics: Adult; Androstane-3,17-diol; Androstanols; Breast; Breast Neoplasms; Epithelium; Female; Humans; Hyperplasia; Middle Aged; Risk; Testosterone

1983
Effect of endocrine manipulations on the levels of cytosolic and nuclear receptors for androgens in dog prostate.
    Investigative urology, 1981, Volume: 18, Issue:8

    Topics: Androstane-3,17-diol; Androstanols; Animals; Castration; Cell Nucleus; Cytoplasm; Dihydrotestosterone; Dogs; Estradiol; Hyperplasia; Male; Prostate; Receptors, Androgen; Receptors, Steroid

1981
Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue.
    Cancer, 1977, Volume: 39, Issue:4

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Carcinoma, Transitional Cell; Dihydrotestosterone; Humans; Hyperplasia; In Vitro Techniques; Male; Prostate; Prostatic Neoplasms; Testosterone

1977
Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
    The Prostate, 1990, Volume: 17, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenes; Anilides; Animals; Azasteroids; Capsules; Carboxylic Ester Hydrolases; Dogs; Dose-Response Relationship, Drug; Estradiol; Finasteride; Flutamide; Hyperplasia; Injections, Intramuscular; Male; Nitriles; Pregnanes; Prostate; Prostatectomy; Pyrazoles; Tosyl Compounds

1990
Differential actions of testosterone and its metabolites on mice submandibular gland.
    Journal de biologie buccale, 1985, Volume: 13, Issue:3

    Topics: Androstane-3,17-diol; Animals; Dihydrotestosterone; DNA; Hyperplasia; Hypertrophy; Male; Mice; Mice, Inbred Strains; Orchiectomy; Salivary Proteins and Peptides; Stereoisomerism; Submandibular Gland; Testosterone

1985